Nephrology
Conference Coverage
Albuminuria linked to higher CVD risk in diabetes
An analysis of more than 74,000 Danish people with type 2 diabetes showed an elevated CVD event rate in those with albuminuria.
From the Journals
Low calcium, potassium key risk factors for kidney stones
“Knowing the dietary factors that are most important for preventing kidney stone recurrence can help patients and providers know what to...
From the Journals
Rosuvastatin again linked with risks to kidneys
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...
Conference Coverage
Could a type 2 diabetes drug tackle kidney stones?
“If this association is proven, empagliflozin may be used to decrease the risk of kidney stones at least in those with type 2 diabetes, but maybe...
Highlights
Updates in aspirin use, aducanumab, and CKD diagnostic criteria in geriatric medicine
Internist gives context and background information regarding new Alzheimer’s therapy.
Conference Coverage
Experts elevate new drugs for diabetic kidney disease
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow...
Conference Coverage
SGLT2 inhibitors cut AFib risk in real-word analysis
Observational data add to a growing link between SGLT2 inhibitor treatment and atrial fibrillation prevention in people with type 2 diabetes.
Guidelines
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR
ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2...
Conference Coverage
Stopping immunosuppressives in lupus nephritis isn’t noninferior to continuing
Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy...
Conference Coverage
Will tirzepatide slow kidney function decline in type 2 diabetes?
Compared to insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with T2D at high...
Conference Coverage
AUA 2022: A report from the trenches
Hundreds of talks and abstracts were presented over the 4 days in New Orleans.